Cancers, Free Full-Text
By A Mystery Man Writer
Description
The Triple Negative Breast Cancer (TNBC) subtype is known to have a more aggressive clinical course compared to other breast cancer subtypes. Targeted therapies for this type of breast cancer are limited and patients are mostly treated with conventional chemo- and radio-therapies which are not specific and do not target resistant cells. Therefore, one of the major clinical challenges is to find compounds that target the drug-resistant cell populations which are responsible for reforming secondary tumours. The molecular profiling of the different TNBC subtypes holds a promise for better defining these resistant cells specific to each tumour. To this end, a better understanding of TNBC heterogeneity and cancer stemness is required, and extensive genomic analysis can help to understand the disease complexity and distinguish new molecular drivers that can be targeted in the clinics. The use of persister cancer cell-targeting therapies combined with other therapies may provide a big advance to improve TNBC patients’ survival.
Cancers, Free Full-Text
PDF) Clinicopathological, Treatment and Event-Free Survival Characteristics in a Moroccan Population of Triple-Negative Breast Cancer
IJMS, Free Full-Text, mdpope 1-3
CA: A Cancer Journal for Clinicians - Wiley Online Library
Cancers, Free Full-Text
Cancers, Free Full-Text
Cancers, Free Full-Text, clube aurora ao vivo
Cancer Today
Cancers, Free Full-Text
20 Encouraging Cancer Quotes for Patients to Inspire Hope
Cancers, Free Full-Text, clube aurora ao vivo
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - ScienceDirect
Cancers, Free Full-Text, kitka games 44
SUNDAY, APRIL 25, 2021 Ad - Comprehensive Blood & Cancer Center - The Bakersfield Californian
Join a FREE Breast Cancer Survivorship Program
from
per adult (price varies by group size)